Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | hypothetical protein | 0.0365 | 0.8496 | 1 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.042 | 1 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0365 | 0.8496 | 0.5 |
Echinococcus multilocularis | fatty acid amide hydrolase 1 | 0.042 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0365 | 0.8496 | 1 |
Chlamydia trachomatis | glutamyl-tRNA(Gln) amidotransferase subunit A | 0.0051 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0365 | 0.8496 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0365 | 0.8496 | 0.5 |
Plasmodium falciparum | lysophospholipase, putative | 0.0365 | 0.8496 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0365 | 0.8496 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0365 | 0.8496 | 1 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0365 | 0.8496 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.042 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0365 | 0.8496 | 0.5 |
Mycobacterium ulcerans | lysophospholipase | 0.0365 | 0.8496 | 1 |
Wolbachia endosymbiont of Brugia malayi | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0051 | 0 | 0.5 |
Plasmodium falciparum | esterase, putative | 0.0365 | 0.8496 | 1 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.042 | 1 | 1 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0365 | 0.8496 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0365 | 0.8496 | 0.5 |
Leishmania major | monoglyceride lipase, putative | 0.0365 | 0.8496 | 1 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0365 | 0.8496 | 0.5 |
Schistosoma mansoni | fatty-acid amide hydrolase | 0.042 | 1 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0365 | 0.8496 | 0.5 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0365 | 0.8496 | 1 |
Schistosoma mansoni | amidase | 0.042 | 1 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0365 | 0.8496 | 1 |
Treponema pallidum | aspartyl/glutamyl-tRNA amidotransferase subunit A | 0.0051 | 0 | 0.5 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0365 | 0.8496 | 0.5 |
Echinococcus granulosus | fatty acid amide hydrolase 1 | 0.042 | 1 | 1 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0365 | 0.8496 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0365 | 0.8496 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0365 | 0.8496 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.